BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 trial.

Current Biology is a scientific journal that covers all areas of biology, especially molecular biology, cell biology, genetics, neurobiology, ecology and evolutionary biology.

Read the latest science news from Phys.org on biology, evolution, microbiology, biotechnology ...

RFK Jr.'s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this administration.

Magnetically steered mesenchymal stem cells significantly lowered intraocular pressure for 9 months in mice, motivating the translation of this technology for the treatment of glaucoma.

Abstract Or101: Effects of pathogenic variation in ADAMTSL4 on vascular smooth muscle cell function relevant to spontaneous coronary artery dissection Cameron Pinnock, BS, MSE, PhD, Kristina Hunker, ...

"MAIA Biotechnology doses first patient in expansion of Phase II lung cancer trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Mechanisms of auxin action in plant growth and development The phytohormone auxin coordinates plant growth by forming local maxima and gradients through cell-to-cell transport and metabolic control.

Given this profile, BEAM-101 has the potential to further restore red blood cell health and function, reduce hospital time for patients, and decrease the overall burden of cell and gene therapy ...